Check! Explore Barriers and Solutions to Data Sharing on BioSense 2.0

Inter-jurisdictional data sharing can enhance disease surveillance capabilities for local, state, regional and national public health situational awareness and response. BioSense 2.0, a cloud-based computing platform for syndromic surveillance, provides participating local, state and federal health jurisdictions with the ability to share aggregated data; a functionality that is easily activated by selecting an administrative checkbox within the BioSense application. Checking the data-sharing box, however, is a considerable decision that comes with benefits and consequences.

August 22, 2018

EHR Conformance Testing for Enhanced Syndromic Surveillance System Interoperability

Lack of speed, reliability, and uniformity of data collection limit the ability of syndromic surveillance (SyS) systems to provide public health authorities (PHAs) with timely information on community health threats and trends. Electronic information technologies have long been used to accelerate and automate data collection for more real-time surveillance. There is, however, irregularity in how SyS data are packaged and sent by healthcare providers.

August 22, 2018

Recommendations for Syndromic Surveillance Using Inpatient and Ambulatory EHR Data

MUse will make EHR data increasingly available for public health surveillance. For Stage 2, the Centers for Medicare & Medicaid Services (CMS) regulations will require hospitals and offer an option for eligible professionals to provide electronic syndromic surveillance data to public health. Together, these data can strengthen public health surveillance capabilities and population health outcomes (Figure 1). To facilitate the adoption and effective use of these data to advance population health, public health priorities and system capabilities must shape standards for data exchange.

July 05, 2018

Utility of Syndromic Surveillance Using Novel Clinical Data Sources

Discusses the current state of syndromic surveillance using inpatient and ambulatory clinical data in the United States and the potential utility of the data. The Meaningful Use Stages 2 and 3 regulations incentivize the use of these data sources. Existing systems effectively perform a range of activities from influenza-like illness surveillance to heart disease risk factor surveillance. With further development, ambulatory and inpatient data could become an integral part of syndromic surveillance practice.

Objective

July 17, 2018

Contact Us

NSSP Community of Practice

Email: syndromic@cste.org

 

This website is supported by Cooperative Agreement # 6NU38OT000297-02-01 Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health between the Centers for Disease Control and Prevention (CDC) and the Council of State and Territorial Epidemiologists. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. CDC is not responsible for Section 508 compliance (accessibility) on private websites.

Site created by Fusani Applications